HST Global Inc. ROIC

ROIC of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROIC growth rates and interactive chart. Return on invested capital (ROIC) is a calculation used to assess a company's efficiency at allocating the capital under its control to profitable investments. Calculated as Net Operating Profit After Tax or EBIT*(1-tax rate) divided by average invested capital. Invested capital is calculated as equity plus long-term and short-term debt minus cash and short-term investments. ROIC is often compared to the Weighted average cost of capital (WACC). If it's above it, it is said the company is creating value, if it's below it's destroying it. A company with after tax operating profit of $10 million and invested capital of $50 million will have a ROIC of 20%.

Highlights and Quick Summary

  • Annual ROIC for 2019 was 0.0% (a NaN% decrease from previous year)
  • Annual ROIC for 2018 was 0.0% (a NaN% decrease from previous year)
  • Annual ROIC for 2017 was 0.0% (a NaN% decrease from previous year)
  • Twelve month ROIC ending June 29, 2020 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing ROIC decreased by -100.0% year-over-year
Trailing ROIC for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.0% 0.0% 0.0% -1969.36%
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROIC of HST Global Inc.

Most recent ROICof HSTC including historical data for past 10 years.

Interactive Chart of ROIC of HST Global Inc.

HST Global Inc. ROIC for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 0.0%
2018 0.0%
2017 0.0%
2016 0.0%
2015 0.0%
2014 0.0%
2013 0.0%
2012 0.0%
2011 0.0%
2010 0.0%
2009 0.0%

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.